Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint blockade efficacy

Malignant pleural mesothelioma (MPM) is an incurable cancer with a dismal prognosis and few effective treatment options. Nonetheless, recent positive phase III trial results for immune checkpoint blockade (ICB) in MPM herald a new dawn in the fight to advance effective treatments for this cancer. Tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Harber, James, Kamata, Tamihiro, Pritchard, Catrin, Fennell, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438820/
https://www.ncbi.nlm.nih.gov/pubmed/34518291
http://dx.doi.org/10.1136/jitc-2021-003032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438820/
https://www.ncbi.nlm.nih.gov/pubmed/34518291
http://dx.doi.org/10.1136/jitc-2021-003032

Ejemplares similares